In today’s time the cost of treatment is increasing. Many such cases have also come to the fore that chemists sell medicines at overrate. To curb this, now the National Pharmaceutical Pricing Authority (NPPA), the regulatory agency for drug prices, has fixed the retail price of 84 medicines. After this, no chemist will be able to sell medicine at over rate.
new price of paracetamol fixed
The prices of essential medicines that NPPA has changed include medicines used in the treatment of diabetes, headache, high blood pressure. With this change, the cost of drugs used to reduce cholesterol and triglyceride levels will also come down. According to the NPPA notification, a Paracetamol-Caffeine tablet will cost Rs 2.88, Rosuvastanin Aspirin and Clopidogrel Capsule will cost Rs 13.91 and Voglibose and (SR) Metformin Hydrochloride tablet will cost Rs 10.47.
The prices of these drugs are also fixed
Talking about other drugs, atorvastatin and fenofibrate tablets sold by Cipla and Pure & Care Healthcare will now be available for Rs 13.87. This medicine is used to treat patients suffering from heart disease and diabetes. Apart from this, the price of one tablet of Voglibose & (SR) Metformin Hydrochloride has been fixed at Rs 10.47 excluding GST.
Instructions to strictly follow orders
The National Pharmaceutical Pricing Authority (NPPA) has said in the notification that pharma companies need to strictly follow the fixed prices. Otherwise, they will have to pay the additional cost along with interest. GST will remain separate after the change in price, but drug manufacturers will be able to recover it only if they themselves have paid GST on the retail price to the government. If any vendor is found selling these medicines at a higher rate, then departmental action will be taken.
Regulator monitors drugs
Based on the Drugs (Prices Control) Order, 2013, the NPPA has fixed the retail prices of medicines. Significantly, the NPPA works to fix the price, control and availability of medicines and formulations in the country. Under this, if a drug producer charges a higher price, then action is taken to recover it. Apart from this, the medicines which are not in the price control list, those medicines are also monitored by the agency.